Celldex Therapeutics Inc. (CLDX)

2.37
0.02 0.85
NASDAQ : Health Technology
Prev Close 2.35
Open 2.33
Day Low/High 2.31 / 2.48
52 Wk Low/High 2.33 / 11.62
Volume 179.34K
Avg Volume 301.20K
Exchange NASDAQ
Shares Outstanding 13.77M
Market Cap 33.46M
EPS -14.50
P/E Ratio N/A
Div & Yield N.A. (N.A)
Perilous Reversal Watch: Celldex Therapeutics (CLDX)

Perilous Reversal Watch: Celldex Therapeutics (CLDX)

Trade-Ideas LLC identified Celldex Therapeutics (CLDX) as a "perilous reversal" (up big yesterday but down big today) candidate

Today's Dead Cat Bounce Stock: Celldex Therapeutics (CLDX)

Today's Dead Cat Bounce Stock: Celldex Therapeutics (CLDX)

Trade-Ideas LLC identified Celldex Therapeutics (CLDX) as a "dead cat bounce" (down big yesterday but up big today) candidate

Celldex Reports Second Quarter 2014 Results

Celldex Reports Second Quarter 2014 Results

Management to Host Conference Call Today, Wednesday, August 6, at 4:30 p.m. Eastern Time

Celldex Therapeutics (CLDX) Is Today's Dead Cat Bounce Stock

Celldex Therapeutics (CLDX) Is Today's Dead Cat Bounce Stock

Trade-Ideas LLC identified Celldex Therapeutics (CLDX) as a "dead cat bounce" (down big yesterday but up big today) candidate

Celldex To Report Second Quarter 2014 Financial Results And Host Corporate 2014 Objectives Update Call

Celldex To Report Second Quarter 2014 Financial Results And Host Corporate 2014 Objectives Update Call

Conference Call Scheduled for Wednesday, August 6 at 4:30 p.m. Eastern Time

Many Ways to Win

Try to find bullish charts that don't all look the same.

3 Stocks Spiking on Unusual Volume

3 Stocks Spiking on Unusual Volume

Often when above-average volume moves into an equity, it precedes a large spike in volatility.

Swing Trade Ideas for Friday, June 6: Celldex, Two Others

Swing Trade Ideas for Friday, June 6: Celldex, Two Others

Celldex broke out yesterday. Does it more room to run? Plus, two other stocks to consider.

Today's Perilous Reversal Stock: Celldex Therapeutics (CLDX)

Today's Perilous Reversal Stock: Celldex Therapeutics (CLDX)

Trade-Ideas LLC identified Celldex Therapeutics (CLDX) as a "perilous reversal" (up big yesterday but down big today) candidate

'Mad Money' Lightning Round: Devon Energy Goes to $90

'Mad Money' Lightning Round: Devon Energy Goes to $90

Cramer is no fan of Nu Skin Enterprises but thinks Alcoa is good.

Jim Cramer's 'Mad Money' Recap: Embrace the Powerful Trends

Jim Cramer's 'Mad Money' Recap: Embrace the Powerful Trends

You can learn a lot by listening to the footsteps of the thundering herd, Cramer says.

'Fast Money' Recap: What's On? How About Netflix Stock?

'Fast Money' Recap: What's On? How About Netflix Stock?

The trading panel discussed Netflix's valuation and whether shares are worth buying.

Perilous Reversal Watch: Celldex Therapeutics (CLDX)

Perilous Reversal Watch: Celldex Therapeutics (CLDX)

Trade-Ideas LLC identified Celldex Therapeutics (CLDX) as a "perilous reversal" (up big yesterday but down big today) candidate

Celldex Therapeutics (CLDX) Showing Signs Of A Dead Cat Bounce Today

Celldex Therapeutics (CLDX) Showing Signs Of A Dead Cat Bounce Today

Trade-Ideas LLC identified Celldex Therapeutics (CLDX) as a "dead cat bounce" (down big yesterday but up big today) candidate

This Beaten-Down Stock Is Ready to Rebound

This Beaten-Down Stock Is Ready to Rebound

Consider buying this oversold stock as it gears up for a big move higher.

Perilous Reversal Watch: Celldex Therapeutics (CLDX)

Perilous Reversal Watch: Celldex Therapeutics (CLDX)

Trade-Ideas LLC identified Celldex Therapeutics (CLDX) as a "perilous reversal" (up big yesterday but down big today) candidate

Why Celldex Therapeutics (CLDX) Stock Is Surging Today

Why Celldex Therapeutics (CLDX) Stock Is Surging Today

Celldex Therapeutics (CLDX) surged Wednesday after the company announced a clinical trial collaboration with Bristol-Myers Squibb (BMY).

Bristol, Celldex Collaborating on Cancer Immunotherapy Study

Bristol, Celldex Collaborating on Cancer Immunotherapy Study

The phase I/II study will combine Bristol's PD-1 checkpoint inhibitor nivolumab with Celldex's CD27-targeted antibody varlilumab, also known as CDX-1127.

Trade-Ideas: Celldex Therapeutics (CLDX) Is Today's "Barbarian At The Gate" Stock

Trade-Ideas: Celldex Therapeutics (CLDX) Is Today's "Barbarian At The Gate" Stock

Trade-Ideas LLC identified Celldex Therapeutics (CLDX) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate

Today's Dead Cat Bounce Stock Is Celldex Therapeutics (CLDX)

Today's Dead Cat Bounce Stock Is Celldex Therapeutics (CLDX)

Trade-Ideas LLC identified Celldex Therapeutics (CLDX) as a "dead cat bounce" (down big yesterday but up big today) candidate

TheStreet Quant Rating: D- (Sell)